about
Methotrexate for ankylosing spondylitis2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisLong-term safety and efficacy of infliximab for the treatment of ankylosing spondylitisSpondyloarthritis: clinical suspicion, diagnosis, and sports.Cervical Spine Involvement: A Rare Manifestation of Reiter's SyndromeAdalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative studyInfluence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.A randomized placebo-controlled trial of methotrexate in psoriatic arthritisEfficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.Treatment of ankylosing spondylitis: focus on etanercept.Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal.Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.Case report--progressive immobilising back and joint pain.
P2860
Q24200564-F6832B45-CE04-40CD-9310-A2E95DC8BCA8Q24603648-BEDF66B0-F04E-4741-A08B-891A30D11200Q26774173-0D93A7A4-ED54-404B-B6BE-59CA0FB2E2A0Q33968580-3C86F471-B171-45F5-8A3E-C798BF13FAC4Q34418924-8855BEA8-5861-4CE1-9823-FAAB00DC29FEQ34449888-7A01BF26-118F-4562-B2D9-AD5ED8A197D6Q34728162-A64D5168-0FC5-4FC9-A1C6-EF2D0C55963CQ35557859-9F234C5C-DD70-4062-A377-CB6ED9209CA4Q35640448-7426F1E1-AA8F-4C49-B181-E98491639BD7Q35708834-F3CC3307-3A99-4575-9872-C0F98DF3E230Q36096798-B5F3930D-47EC-4530-B61F-CE278A65355CQ36876679-230CC0B0-7BE1-4E98-91F4-9F08D4538C0AQ37191464-78615887-472F-4185-AEC1-958CBC905D9EQ37290601-10F63836-FC25-49E1-A529-B20F8809A627Q38098483-37B711D3-D9F0-4409-8CBD-B2EB0117CA1DQ39135959-6363D752-56B0-4155-ADE2-19E4815796DBQ39879032-CC69F085-7D63-4A83-89A3-363FFB6836FA
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Methotrexate for ankylosing spondylitis
@ast
Methotrexate for ankylosing spondylitis
@en
Methotrexate for ankylosing spondylitis
@en-gb
Methotrexate for ankylosing spondylitis
@nl
type
label
Methotrexate for ankylosing spondylitis
@ast
Methotrexate for ankylosing spondylitis
@en
Methotrexate for ankylosing spondylitis
@en-gb
Methotrexate for ankylosing spondylitis
@nl
prefLabel
Methotrexate for ankylosing spondylitis
@ast
Methotrexate for ankylosing spondylitis
@en
Methotrexate for ankylosing spondylitis
@en-gb
Methotrexate for ankylosing spondylitis
@nl
P2093
P2860
P1476
Methotrexate for ankylosing spondylitis
@en
P2093
Junfang Lin
Junmin Chen
P2860
P356
10.1002/14651858.CD004524.PUB3
P577
2006-10-18T00:00:00Z